This conference is the second international meeting on DUBs and is unique in its focus on this class of enzymes. It will bring together researchers in this exciting field of research to discuss molecular mechanisms, cellular functions and physiological roles of DUBs. The recent development of highly specific inhibitors has led to a lot of interest in exploring these enzymes as therapeutic drug targets in a variety of disease settings ranging from infection and inflammation to cancer and neurodegeneration. Emerging new concepts in DUB regulation and translation will be a particular focus of this meeting.
Oral communication slots are available at this meeting. All attendees, particularly researchers in the early stages of their career, are invited to submit a poster abstract for consideration as an oral communication.
Abstract Submission Guidelines The maximum number of words allowed in your abstract body is 230.
Please type your abstract straight into the online submission form, or alternatively paste the text from a word-processed document.
The ‘Full title’ should be presented sentence case (not in Title Case or BLOCK CAPITALS), that is only the first letter of the title or appropriate terms such as abbreviations or proper nouns should be upper case.
Has my abstract been accepted? Approximately 2 weeks after the abstract submission deadline has passed, you will receive an email informing you whether your abstract has been accepted/rejected as an oral communication or poster. All abstracts will be available to view online.
Sign up and follow your favorite conferences.